Dow Jones

39 118,86

-0,12%

DAX

Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
USOTC
Capstone Therapeutics Corporation (QB) (CAPS)
Capstone Therapeutics Corporation (QB) (CAPS) Actualités

CAPS

Capstone Therapeutics (QB) (CAPS)

Capstone Therapeutics Corporation (QB)

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:USOTC:CAPS

1 2 3 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
25/09/2019	22h01	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(g) (15-12g)	USOTC:CAPS	Capstone Therapeutics Corporation (QB)
09/09/2019	15h02	Edgar (US Regulatory)	Amended Statement of Ownership: Private Transaction (sc 13e3/a)	USOTC:CAPS	Capstone Therapeutics Corporation (QB)
26/08/2019	22h00	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:CAPS	Capstone Therapeutics Corporation (QB)
20/08/2019	23h25	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	USOTC:CAPS	Capstone Therapeutics Corporation (QB)
13/08/2019	15h02	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:CAPS	Capstone Therapeutics Corporation (QB)
10/07/2019	22h02	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	USOTC:CAPS	Capstone Therapeutics Corporation (QB)
03/07/2019	20h41	Edgar (US Regulatory)	Proxy Soliciting Materials (revised) (prer14a)	USOTC:CAPS	Capstone Therapeutics Corporation (QB)
31/05/2019	22h48	Edgar (US Regulatory)	Statement of Ownership: Private Transaction (sc 13e3)	USOTC:CAPS	Capstone Therapeutics Corporation (QB)
31/05/2019	22h04	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	USOTC:CAPS	Capstone Therapeutics Corporation (QB)
22/03/2019	21h04	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:CAPS	Capstone Therapeutics Corporation (QB)
21/03/2019	14h03	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	USOTC:CAPS	Capstone Therapeutics Corporation (QB)
13/02/2019	22h46	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	USOTC:CAPS	Capstone Therapeutics Corporation (QB)
11/02/2019	19h02	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	USOTC:CAPS	Capstone Therapeutics Corporation (QB)
04/02/2019	21h53	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	USOTC:CAPS	Capstone Therapeutics Corporation (QB)
28/12/2018	18h38	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:CAPS	Capstone Therapeutics Corporation (QB)
30/10/2017	21h03	Edgar (US Regulatory)	Amended Annual Report (10-k/a)	USOTC:CAPS	Capstone Therapeutics Corporation (QB)
24/07/2017	23h11	Edgar (US Regulatory)	Statement of Beneficial Ownership (sc 13d)	USOTC:CAPS	Capstone Therapeutics Corporation (QB)
17/07/2017	23h09	Edgar (US Regulatory)	Small Company Offering and Sale of Securities Without Registration (d)	USOTC:CAPS	Capstone Therapeutics Corporation (QB)
19/04/2017	15h01	Edgar (US Regulatory)	Securities Registration (section 12(g)) (8-a12g)	USOTC:CAPS	Capstone Therapeutics Corporation (QB)
16/09/2015	15h04	Edgar (US Regulatory)	Securities Registration Statement (s-1/a)	USOTC:CAPS	Capstone Therapeutics Corporation (QB)
26/06/2015	21h50	Edgar (US Regulatory)	Securities Registration Statement (s-1)	USOTC:CAPS	Capstone Therapeutics Corporation (QB)
23/06/2015	21h10	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	USOTC:CAPS	Capstone Therapeutics Corporation (QB)
27/04/2015	21h46	InvestorsHub NewsWire	EDISON EQUITY RESEARCH - CAPSTONE THERAPEUTICS	USOTC:CAPS	Capstone Therapeutics Corporation (QB)
24/06/2014	17h37	Edgar (US Regulatory)	Amended Securities Registration (section 12(g)) (8-a12g/a)	USOTC:CAPS	Capstone Therapeutics Corporation (QB)
24/06/2014	16h01	Edgar (US Regulatory)	(25)	USOTC:CAPS	Capstone Therapeutics Corporation (QB)
11/06/2014	18h47	GlobeNewswire Inc.	Capstone Therapeutics Announces Initiation of Dosing for AEM-28 Phase 1b/2a Human Clinical Trial in Refractory Hypercholester...	USOTC:CAPS	Capstone Therapeutics Corporation (QB)
16/05/2014	19h00	GlobeNewswire Inc.	Capstone Therapeutics Announces Operating Update Conference Call	USOTC:CAPS	Capstone Therapeutics Corporation (QB)
08/04/2014	15h00	GlobeNewswire Inc.	Capstone Therapeutics Announces Initiation of Dosing for AEM-28 Phase 1 Human Clinical Trial in LDL/non-HDL Cholesterol Reduc...	USOTC:CAPS	Capstone Therapeutics Corporation (QB)
27/03/2014	14h02	Edgar (US Regulatory)	Post-effective Amendment (investment Company, Rule 485(b)) (485bpos)	USOTC:CAPS	Capstone Therapeutics Corporation (QB)
27/03/2014	14h02	Edgar (US Regulatory)	Mutual Fund Summary Prospectus (497k)	USOTC:CAPS	Capstone Therapeutics Corporation (QB)